US Stock MarketDetailed Quotes

Medpace (MEDP)

Watchlist

457.090
-4.510-0.98%

Close Jun 17 16:00 ET

456.500
-0.590-0.13%

Post 20:01 ET

13.05BMarket Cap28.77P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Medpace (MEDP) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.62%151.79M

17.15%713.22M

1.04%192.65M

65.16%246.21M

27.60%148.53M

-17.58%125.84M

40.48%608.82M

21.91%190.67M

30.33%149.08M

41.06%116.4M

Net income from continuing operations

8.09%123.87M

11.56%451.12M

15.48%135.13M

15.25%111.14M

2.16%90.26M

11.70%114.6M

42.99%404.39M

49.45%117.02M

36.68%96.43M

44.68%88.35M

Depreciation and amortization

-0.35%6.91M

-3.85%28.12M

-5.00%7.13M

-6.24%7.05M

-3.05%7.01M

-0.89%6.93M

11.10%29.25M

7.66%7.51M

9.31%7.52M

10.97%7.24M

Deferred tax

2,375.70%18.54M

403.29%80.77M

171.93%17.41M

1,983.09%28.51M

63,261.11%34.11M

186.59%749K

-6.03%-26.63M

-75.24%-24.2M

80.08%-1.51M

97.96%-54K

Other non cash items

12.35%6.25M

15.82%22.14M

-7.14%5.24M

-3.08%5.73M

-7.99%5.61M

279.40%5.56M

-14.48%19.12M

-18.77%5.65M

-10.98%5.91M

11.62%6.09M

Change In working capital

53.96%-8.7M

-38.75%96.28M

-71.93%22.12M

201.52%87.46M

-50.03%5.59M

-149.48%-18.89M

47.61%157.18M

8.22%78.81M

-11.86%29.01M

55.09%11.19M

-Change in receivables

478.06%7.82M

-4,837.51%-106.22M

-290.49%-29.1M

147.11%4.86M

-266.06%-79.91M

-110.82%-2.07M

104.64%2.24M

270.32%15.27M

41.31%-10.32M

-25.53%-21.83M

-Change in prepaid assets

89.77%-1.8M

-124.16%-27.1M

-1,070.47%-11.49M

12,153.85%17.52M

-661.34%-15.58M

-90.69%-17.55M

-504.89%-12.09M

-108.22%-982K

-95.03%143K

-25.83%-2.05M

-Change in payables and accrued expense

90.23%-1.22M

616.48%99.71M

1,257.29%40.9M

177.66%34.55M

36.24%36.71M

56.32%-12.44M

-83.26%13.92M

-89.66%3.01M

-59.08%12.44M

-5.48%26.95M

-Change in other current liabilities

19.15%-5.29M

-17.53%-25.16M

-17.35%-7.03M

-25.59%-5.52M

-19.45%-6.07M

-10.12%-6.55M

-13.43%-21.41M

-34.91%-5.99M

13.10%-4.39M

-24.03%-5.08M

-Change in other working capital

-141.66%-8.22M

-11.16%155.04M

-57.27%28.84M

15.79%36.05M

433.79%70.43M

-68.55%19.72M

99.40%174.52M

49.46%67.49M

39.83%31.13M

626.60%13.2M

Cash from discontinued investing activities

Operating cash flow

20.62%151.79M

17.15%713.22M

1.04%192.65M

65.16%246.21M

27.60%148.53M

-17.58%125.84M

40.48%608.82M

21.91%190.67M

30.33%149.08M

41.06%116.4M

Investing cash flow

Cash flow from continuing investing activities

32.43%-6.75M

-10.00%-31.14M

40.85%-4.47M

-1.66%-10.66M

52.93%-6.02M

-494.74%-9.99M

18.25%-28.31M

5.44%-7.56M

-21.06%-10.49M

-51.06%-12.79M

Capital expenditure reported

31.82%-6.81M

----

52.51%-6.11M

-81.81%-9.99M

----

---12.87M

Net PPE purchase and sale

----

14.21%-31.36M

40.65%-4.54M

----

0.27%-36.55M

23.46%-7.64M

----

Net other investing changes

842.86%66K

-97.38%216K

-22.22%63K

3.92%53K

14.81%93K

-99.91%7K

308.12%8.24M

-95.93%81K

24.39%51K

485.71%81K

Cash from discontinued investing activities

Investing cash flow

32.43%-6.75M

-10.00%-31.14M

40.85%-4.47M

-1.66%-10.66M

52.93%-6.02M

-494.74%-9.99M

18.25%-28.31M

5.44%-7.56M

-21.06%-10.49M

-51.06%-12.79M

Financing cash flow

Cash flow from continuing financing activities

103.66%12.67M

-458.66%-860.39M

113.48%22.73M

-45.60%3.41M

-81,265.77%-540.56M

-4,616.53%-345.97M

15.68%-154.01M

-11,170.85%-168.61M

112.73%6.27M

100.81%666K

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

--0

-440.06%-917.39M

--0

---4.57M

---540.92M

---371.9M

-17.95%-169.87M

---169.87M

--0

Proceeds from stock option exercised by employees

-51.15%12.67M

259.45%57M

1,706.76%22.73M

27.30%7.99M

-47.30%351K

238.56%25.93M

39.37%15.86M

-17.40%1.26M

9.53%6.27M

-59.98%666K

Cash from discontinued financing activities

Financing cash flow

103.66%12.67M

-458.66%-860.39M

113.48%22.73M

-45.60%3.41M

-81,265.77%-540.56M

-4,616.53%-345.97M

15.68%-154.01M

-11,170.85%-168.61M

112.73%6.27M

100.81%666K

Net cash flow

Beginning cash position

-25.75%497.05M

172.74%669.44M

-56.56%285.35M

-90.93%46.33M

8.46%441.44M

172.74%669.44M

768.38%245.45M

589.97%656.9M

1,205.37%510.89M

767.42%407.01M

Current changes in cash

168.53%157.71M

-141.81%-178.31M

1,355.04%210.91M

64.96%238.96M

-481.75%-398.06M

-241.29%-230.12M

97.36%426.5M

-90.33%14.5M

156.62%144.86M

1,378.01%104.27M

Effect of exchange rate changes

-198.16%-2.08M

335.68%5.92M

140.33%790K

-94.84%59K

858.87%2.95M

262.10%2.12M

-332.28%-2.51M

-710.28%-1.96M

399.21%1.14M

-203.73%-389K

End cash Position

47.85%652.68M

-25.75%497.05M

-56.56%285.35M

-90.93%46.33M

8.46%441.44M

172.74%669.44M

589.97%656.9M

1,205.37%510.89M

Free cash flow

25.15%144.97M

19.15%681.87M

2.78%188.12M

69.99%235.5M

37.56%142.41M

-21.29%115.84M

44.25%572.27M

25.01%183.02M

31.09%138.54M

39.76%103.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.62%151.79M	17.15%713.22M	1.04%192.65M	65.16%246.21M	27.60%148.53M	-17.58%125.84M	40.48%608.82M	21.91%190.67M	30.33%149.08M	41.06%116.4M
Net income from continuing operations	8.09%123.87M	11.56%451.12M	15.48%135.13M	15.25%111.14M	2.16%90.26M	11.70%114.6M	42.99%404.39M	49.45%117.02M	36.68%96.43M	44.68%88.35M
Depreciation and amortization	-0.35%6.91M	-3.85%28.12M	-5.00%7.13M	-6.24%7.05M	-3.05%7.01M	-0.89%6.93M	11.10%29.25M	7.66%7.51M	9.31%7.52M	10.97%7.24M
Deferred tax	2,375.70%18.54M	403.29%80.77M	171.93%17.41M	1,983.09%28.51M	63,261.11%34.11M	186.59%749K	-6.03%-26.63M	-75.24%-24.2M	80.08%-1.51M	97.96%-54K
Other non cash items	12.35%6.25M	15.82%22.14M	-7.14%5.24M	-3.08%5.73M	-7.99%5.61M	279.40%5.56M	-14.48%19.12M	-18.77%5.65M	-10.98%5.91M	11.62%6.09M
Change In working capital	53.96%-8.7M	-38.75%96.28M	-71.93%22.12M	201.52%87.46M	-50.03%5.59M	-149.48%-18.89M	47.61%157.18M	8.22%78.81M	-11.86%29.01M	55.09%11.19M
-Change in receivables	478.06%7.82M	-4,837.51%-106.22M	-290.49%-29.1M	147.11%4.86M	-266.06%-79.91M	-110.82%-2.07M	104.64%2.24M	270.32%15.27M	41.31%-10.32M	-25.53%-21.83M
-Change in prepaid assets	89.77%-1.8M	-124.16%-27.1M	-1,070.47%-11.49M	12,153.85%17.52M	-661.34%-15.58M	-90.69%-17.55M	-504.89%-12.09M	-108.22%-982K	-95.03%143K	-25.83%-2.05M
-Change in payables and accrued expense	90.23%-1.22M	616.48%99.71M	1,257.29%40.9M	177.66%34.55M	36.24%36.71M	56.32%-12.44M	-83.26%13.92M	-89.66%3.01M	-59.08%12.44M	-5.48%26.95M
-Change in other current liabilities	19.15%-5.29M	-17.53%-25.16M	-17.35%-7.03M	-25.59%-5.52M	-19.45%-6.07M	-10.12%-6.55M	-13.43%-21.41M	-34.91%-5.99M	13.10%-4.39M	-24.03%-5.08M
-Change in other working capital	-141.66%-8.22M	-11.16%155.04M	-57.27%28.84M	15.79%36.05M	433.79%70.43M	-68.55%19.72M	99.40%174.52M	49.46%67.49M	39.83%31.13M	626.60%13.2M
Cash from discontinued investing activities
Operating cash flow	20.62%151.79M	17.15%713.22M	1.04%192.65M	65.16%246.21M	27.60%148.53M	-17.58%125.84M	40.48%608.82M	21.91%190.67M	30.33%149.08M	41.06%116.4M
Investing cash flow
Cash flow from continuing investing activities	32.43%-6.75M	-10.00%-31.14M	40.85%-4.47M	-1.66%-10.66M	52.93%-6.02M	-494.74%-9.99M	18.25%-28.31M	5.44%-7.56M	-21.06%-10.49M	-51.06%-12.79M
Capital expenditure reported	31.82%-6.81M	----	----	----	52.51%-6.11M	-81.81%-9.99M	----	----	----	---12.87M
Net PPE purchase and sale	----	14.21%-31.36M	40.65%-4.54M	----	----	----	0.27%-36.55M	23.46%-7.64M	----	----
Net other investing changes	842.86%66K	-97.38%216K	-22.22%63K	3.92%53K	14.81%93K	-99.91%7K	308.12%8.24M	-95.93%81K	24.39%51K	485.71%81K
Cash from discontinued investing activities
Investing cash flow	32.43%-6.75M	-10.00%-31.14M	40.85%-4.47M	-1.66%-10.66M	52.93%-6.02M	-494.74%-9.99M	18.25%-28.31M	5.44%-7.56M	-21.06%-10.49M	-51.06%-12.79M
Financing cash flow
Cash flow from continuing financing activities	103.66%12.67M	-458.66%-860.39M	113.48%22.73M	-45.60%3.41M	-81,265.77%-540.56M	-4,616.53%-345.97M	15.68%-154.01M	-11,170.85%-168.61M	112.73%6.27M	100.81%666K
Net issuance payments of debt	----	--0	----	----	----	----	--0	--0	--0	----
Net common stock issuance	--0	-440.06%-917.39M	--0	---4.57M	---540.92M	---371.9M	-17.95%-169.87M	---169.87M	--0	--0
Proceeds from stock option exercised by employees	-51.15%12.67M	259.45%57M	1,706.76%22.73M	27.30%7.99M	-47.30%351K	238.56%25.93M	39.37%15.86M	-17.40%1.26M	9.53%6.27M	-59.98%666K
Cash from discontinued financing activities
Financing cash flow	103.66%12.67M	-458.66%-860.39M	113.48%22.73M	-45.60%3.41M	-81,265.77%-540.56M	-4,616.53%-345.97M	15.68%-154.01M	-11,170.85%-168.61M	112.73%6.27M	100.81%666K
Net cash flow
Beginning cash position	-25.75%497.05M	172.74%669.44M	-56.56%285.35M	-90.93%46.33M	8.46%441.44M	172.74%669.44M	768.38%245.45M	589.97%656.9M	1,205.37%510.89M	767.42%407.01M
Current changes in cash	168.53%157.71M	-141.81%-178.31M	1,355.04%210.91M	64.96%238.96M	-481.75%-398.06M	-241.29%-230.12M	97.36%426.5M	-90.33%14.5M	156.62%144.86M	1,378.01%104.27M
Effect of exchange rate changes	-198.16%-2.08M	335.68%5.92M	140.33%790K	-94.84%59K	858.87%2.95M	262.10%2.12M	-332.28%-2.51M	-710.28%-1.96M	399.21%1.14M	-203.73%-389K
End cash Position	47.85%652.68M	-25.75%497.05M	-25.75%497.05M	-56.56%285.35M	-90.93%46.33M	8.46%441.44M	172.74%669.44M	172.74%669.44M	589.97%656.9M	1,205.37%510.89M
Free cash flow	25.15%144.97M	19.15%681.87M	2.78%188.12M	69.99%235.5M	37.56%142.41M	-21.29%115.84M	44.25%572.27M	25.01%183.02M	31.09%138.54M	39.76%103.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More

牛牛課堂

Jun 15 14:46

美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？

Queen女王学期权

Jun 15 16:22

After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks